Remicade (infliximab) - J&J
Bimzelx (bimekizumab-bkzx) - UCB
Humira (adalimumab) - AbbVie
Cosentyx (secukinumab) - Novartis
Stelara (ustekinumab) - J&J
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Rinvoq (upadacitinib) - AbbVie
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=829448&rnd=0.9524601
 
Jonathan Hong; MD; Dana Cornwell; DO; Praveena Mylvaganam; MD
 
Aug 29, 2026
 
Prev Next